A Phase II Study of the Combination Chemotherapy of Bevacizumab and Gemcitabine in Women With Platinum-Resistant Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Journal of Ovarian Research - United Kingdom
doi 10.1186/s13048-020-0617-y
Full Text
Open PDFAbstract
Available in full text
Date
February 7, 2020
Authors
Publisher
Society for Mining, Metallurgy and Exploration Inc.